A detailed history of Credit Suisse Ag transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Credit Suisse Ag holds 197,789 shares of IRWD stock, worth $698,195. This represents 0.0% of its overall portfolio holdings.

Number of Shares
197,789
Previous 5,612,113 96.48%
Holding current value
$698,195
Previous $64.2 Million 97.32%
% of portfolio
0.0%
Previous 0.06%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$8.32 - $15.45 $45 Million - $83.7 Million
-5,414,324 Reduced 96.48%
197,789 $1.72 Million
Q4 2023

Feb 08, 2024

BUY
$8.79 - $11.51 $9.76 Million - $12.8 Million
1,110,544 Added 24.67%
5,612,113 $64.2 Million
Q3 2023

Nov 13, 2023

SELL
$8.25 - $11.35 $10.7 Million - $14.7 Million
-1,298,944 Reduced 22.39%
4,501,569 $43.4 Million
Q2 2023

Aug 11, 2023

BUY
$10.1 - $11.6 $6.35 Million - $7.29 Million
628,844 Added 12.16%
5,800,513 $61.7 Million
Q1 2023

May 10, 2023

SELL
$10.37 - $12.56 $301,082 - $364,667
-29,034 Reduced 0.56%
5,171,669 $54.4 Million
Q4 2022

Feb 13, 2023

BUY
$9.9 - $12.43 $5.52 Million - $6.93 Million
557,798 Added 12.01%
5,200,703 $64.4 Million
Q3 2022

Nov 10, 2022

BUY
$10.14 - $12.38 $2.24 Million - $2.74 Million
221,377 Added 5.01%
4,642,905 $48.1 Million
Q2 2022

Aug 12, 2022

SELL
$11.05 - $12.72 $480,896 - $553,574
-43,520 Reduced 0.97%
4,421,528 $51 Million
Q1 2022

May 16, 2022

SELL
$10.61 - $12.88 $1.71 Million - $2.08 Million
-161,535 Reduced 3.49%
4,465,048 $56.2 Million
Q4 2021

Feb 14, 2022

SELL
$10.86 - $13.95 $263,984 - $339,096
-24,308 Reduced 0.52%
4,626,583 $53.9 Million
Q3 2021

Nov 12, 2021

BUY
$11.92 - $13.92 $7.09 Million - $8.28 Million
594,844 Added 14.67%
4,650,891 $60.7 Million
Q2 2021

Aug 16, 2021

BUY
$10.16 - $13.11 $3.54 Million - $4.57 Million
348,217 Added 9.39%
4,056,047 $52.2 Million
Q1 2021

May 14, 2021

SELL
$9.04 - $11.86 $1.12 Million - $1.46 Million
-123,521 Reduced 3.22%
3,707,830 $41.5 Million
Q4 2020

Feb 12, 2021

BUY
$9.05 - $12.2 $1.56 Million - $2.1 Million
172,393 Added 4.71%
3,831,351 $43.6 Million
Q3 2020

Nov 13, 2020

SELL
$8.99 - $10.74 $384,151 - $458,930
-42,731 Reduced 1.15%
3,658,958 $32.9 Million
Q2 2020

Aug 12, 2020

BUY
$9.14 - $11.97 $2.52 Million - $3.3 Million
275,931 Added 8.05%
3,701,689 $38.2 Million
Q1 2020

May 13, 2020

BUY
$8.58 - $14.01 $3.11 Million - $5.08 Million
362,615 Added 11.84%
3,425,758 $34.6 Million
Q4 2019

Feb 12, 2020

SELL
$8.22 - $14.0 $2 Million - $3.41 Million
-243,779 Reduced 7.37%
3,063,143 $40.8 Million
Q3 2019

Nov 12, 2019

BUY
$8.59 - $10.96 $11.9 Million - $15.2 Million
1,385,005 Added 72.06%
3,306,922 $28.4 Million
Q2 2019

Aug 14, 2019

BUY
$9.8 - $12.89 $3.18 Million - $4.19 Million
324,714 Added 20.33%
1,921,917 $21 Million
Q1 2019

May 14, 2019

BUY
$8.27 - $12.73 $52,944 - $81,497
6,402 Added 0.4%
1,597,203 $21.6 Million
Q4 2018

Feb 13, 2019

BUY
$7.8 - $16.13 $1.65 Million - $3.42 Million
212,137 Added 15.39%
1,590,801 $16.5 Million
Q3 2018

Nov 13, 2018

BUY
$14.31 - $17.65 $917,471 - $1.13 Million
64,114 Added 4.88%
1,378,664 $25.5 Million
Q2 2018

Aug 14, 2018

SELL
$11.83 - $16.2 $2.75 Million - $3.77 Million
-232,863 Reduced 15.05%
1,314,550 $25.1 Million
Q1 2018

May 15, 2018

SELL
$11.13 - $13.63 $254,543 - $311,718
-22,870 Reduced 1.46%
1,547,413 $23.9 Million
Q4 2017

Feb 14, 2018

SELL
$12.16 - $14.58 $547 - $656
-45 Reduced -0.0%
1,570,283 $23.5 Million
Q3 2017

Nov 14, 2017

BUY
$12.07 - $14.87 $2.74 Million - $3.37 Million
226,752 Added 16.88%
1,570,328 $24.8 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,343,576
1,343,576 $25.4 Million

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $541M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.